96 related articles for article (PubMed ID: 1093294)
1. Tumor inhibitory properties of anaerobic Corynebacteria.
Woodruff MF
Transplant Proc; 1975 Jun; 7(2):229-32. PubMed ID: 1093294
[No Abstract] [Full Text] [Related]
2. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
Milas L; Hunter N; Withers HR
Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
[No Abstract] [Full Text] [Related]
3. Protection by Corynebacterium parvum against tumour cells injected intravenously.
Milas L; Mujagić H
Rev Eur Etud Clin Biol; 1972 May; 17(5):498-500. PubMed ID: 4648182
[No Abstract] [Full Text] [Related]
4. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
Woodruff MF; McBride WH; Dunbar N
Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
Mitcheson HD; Priestman TJ
Clin Oncol; 1981 Sep; 7(3):179-82. PubMed ID: 7044635
[No Abstract] [Full Text] [Related]
6. The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.
Woodruff M; Dunbar N; Ghaffar A
Proc R Soc Lond B Biol Sci; 1973 Aug; 184(1074):97-102. PubMed ID: 4147951
[No Abstract] [Full Text] [Related]
7. A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum.
Peters LJ; McBride WH; Mason KA; Milas L
J Reticuloendothel Soc; 1978 Jul; 24(1):9-18. PubMed ID: 308542
[No Abstract] [Full Text] [Related]
8. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
9. [Stimulating immunity with the use of Corynebacterium parvum after resection of carcinoma of bronchial origin. Clinical aspects].
Dangubić V; Dujić A; Lilić D; Kolasinović N; Jeremić K
Srp Arh Celok Lek; 1982 Sep; 110(9):1017-24. PubMed ID: 7182936
[No Abstract] [Full Text] [Related]
10. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tumor cells and activated macrophages in vitro: modulation by Corynebacterium parvum and gold salt.
Ghaffar A; McBride WH; Cullen RT
J Reticuloendothel Soc; 1976 Oct; 20(4):283-9. PubMed ID: 825644
[No Abstract] [Full Text] [Related]
12. Doxorubicin, cisplatin, and Corynebacterium parvum in non-small cell bronchogenic carcinoma.
Drapkin R; Bjornsson S; Naeher C; Higby D; Caracandas J; Wallens WT; Kuberka N; Suh K; Siddiqi N; Henderson ES
Cancer Treat Rep; 1980; 64(12):1367-9. PubMed ID: 7193520
[TBL] [Abstract][Full Text] [Related]
13. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
[TBL] [Abstract][Full Text] [Related]
14. The effect of Corynebacterium parvum on T cell dependent tumor regression.
McBride WH; Peters LJ; Mason KA; Barrow G
J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
[No Abstract] [Full Text] [Related]
15. Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A.
Magnarin M; Bergamo A; Carotenuto ME; Zorzet S; Sava G
Anticancer Res; 2000; 20(5A):2939-44. PubMed ID: 11062704
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
Sava G; Perissin L; Zorzet S; Callerio C
Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
[TBL] [Abstract][Full Text] [Related]
17. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
[TBL] [Abstract][Full Text] [Related]
18. [Corynebacteria--stimulators of antitumor resistance].
Zatula DG; Zaval'niuk AK; Tofan AV
Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
20. [Immunopotentiation in the treatment of malignant diseases. Cellular immunity in patients with malignoma of the lung treated with Corynebacterium parvum].
Dujić A; Dangubić V; Lilić D; Kolasinović N
Vojnosanit Pregl; 1982; 39(4):298-301. PubMed ID: 7147792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
